JPH01175855A - Surgical monofilament seaming thread - Google Patents
Surgical monofilament seaming threadInfo
- Publication number
- JPH01175855A JPH01175855A JP62335283A JP33528387A JPH01175855A JP H01175855 A JPH01175855 A JP H01175855A JP 62335283 A JP62335283 A JP 62335283A JP 33528387 A JP33528387 A JP 33528387A JP H01175855 A JPH01175855 A JP H01175855A
- Authority
- JP
- Japan
- Prior art keywords
- monofilament
- thread
- polycaprolactin
- seaming thread
- suture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004826 seaming Methods 0.000 title abstract 7
- 229920001610 polycaprolactone Polymers 0.000 claims description 28
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 229920000642 polymer Polymers 0.000 abstract description 5
- 239000003054 catalyst Substances 0.000 abstract description 4
- -1 halide tin compound Chemical class 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 239000000178 monomer Substances 0.000 abstract description 3
- 238000009987 spinning Methods 0.000 abstract description 3
- 229920001169 thermoplastic Polymers 0.000 abstract description 3
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 3
- 229920001577 copolymer Polymers 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 239000011261 inert gas Substances 0.000 abstract description 2
- 239000003999 initiator Substances 0.000 abstract description 2
- 238000007142 ring opening reaction Methods 0.000 abstract description 2
- 150000003606 tin compounds Chemical class 0.000 abstract description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 abstract 1
- 230000000379 polymerizing effect Effects 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
- 150000003609 titanium compounds Chemical class 0.000 abstract 1
- 239000004632 polycaprolactone Substances 0.000 description 12
- 229920000954 Polyglycolide Polymers 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 239000004633 polyglycolic acid Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000000137 annealing Methods 0.000 description 2
- 239000002729 catgut Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000002074 melt spinning Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical group O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は外科手術用縫合糸、詳しくはポリカプロラクト
ン重合体からなり、しなやかにして充分な強力を有し、
長期に亘って生体内に吸収される外科用モノフィラメン
ト縫合糸に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a surgical suture, specifically made of a polycaprolactone polymer, which is flexible and has sufficient strength.
The present invention relates to a surgical monofilament suture that is absorbed into the body over a long period of time.
(従来の技術)
外科用の縫合糸はその形状からモノフィラメントと撚り
糸や編組糸のようなマルチフィラメントに大別され、そ
の素材としては、ナイロン、ポリエステル、ポリプロピ
レン等の合成重合体やステンレススチール等の不錆性金
属線あるいは絹糸等の動物性繊維が汎用されている。(Prior art) Surgical sutures are broadly classified into monofilaments and multifilaments such as twisted threads and braided threads based on their shape, and their materials include synthetic polymers such as nylon, polyester, and polypropylene, and stainless steel. Rust-proof metal wire or animal fibers such as silk thread are commonly used.
また、近年においては高分子量のポリカプロラクトンが
医療用として注目されるに至り、特開昭62−6055
7号公報にみられるように、ポリカプロラクトン重合体
が縫合糸の被覆用として用いられている。In addition, in recent years, high molecular weight polycaprolactone has attracted attention for medical use, and
As seen in US Pat. No. 7, polycaprolactone polymers have been used to coat sutures.
(発明が解決しようとする問題点)
一般にモノフィラメント縫合糸は、表面が滑らかである
ため使用時における組織通過性が良好であるという長所
を有しているが、素材の硬さがそのまま、糸の硬さとし
て現れることから糸が硬く感じられ、包装のために糸を
幾重にも輪状に巻いた際、その輪状の巻きくせが残留し
て取扱いにくくなるという不都合が生じる。(Problems to be Solved by the Invention) In general, monofilament sutures have a smooth surface and have the advantage of good tissue passage during use. This appearance of hardness makes the thread feel stiff, and when the thread is wound into a ring for packaging, the ring-like curls remain, making it difficult to handle.
一方マルチフィラメント縫合糸は、モノフィラメントに
比べて遥かに柔軟であり、曲げ弾性率が低く、くり返し
の曲げに対する強さの点において優れているが、反面に
おいて表面の平滑性に欠けるため表面コーティングの処
理が必要となる。このコーティング処理は安全な結節回
数の調整に役立つがコーティング剤が生体非吸収性であ
る場合には糸表面から剥離したコーティング剤が異物と
して体内に拡散する危険がともなうため、コーティング
剤の素材には細心の配慮が必要となる。On the other hand, multifilament sutures are much more flexible than monofilament sutures, have a lower flexural modulus, and are superior in terms of strength against repeated bending, but on the other hand, they lack surface smoothness and require surface coating treatment. Is required. This coating process is useful for safely adjusting the number of knots, but if the coating agent is non-bioabsorbable, there is a risk that the coating agent peeled off from the thread surface will diffuse into the body as foreign matter, so the material of the coating agent is Careful consideration is required.
(問題点を解決するための手段)
本発明は上記した医療用縫合糸、殊にモノフィラメント
縫合糸の高い曲げ弾性率(ヤング率)しなやかさの不足
という不都合が改善されたモノフィラメント縫合糸を提
供するものであり、相対粘度2.0〜8.2のポリカプ
ロラクトン重合体を線状に溶融紡糸し、延伸処理を施し
て所定太さのモノフィラメント縫合糸となしたものであ
る。(Means for Solving the Problems) The present invention provides a medical suture described above, particularly a monofilament suture that has improved the disadvantages of monofilament suture, such as high flexural modulus (Young's modulus) and lack of flexibility. A polycaprolactone polymer having a relative viscosity of 2.0 to 8.2 is melt-spun into a linear shape and subjected to a drawing process to form a monofilament suture thread of a predetermined thickness.
ポリカプロラクトン重合体は非毒性であって生体組織内
で徐々に分解吸収されるという縫合糸としての好ましい
性質を有している。この種の分野に縫合糸の被覆用とし
て利用されているポリカプロラクトン重合体は相対粘度
1.8〜1.5であるが、本発明においては相対粘度2
.0〜8.2であり、ヤング率が小さく、シたがって、
しなやかさのあるモノフィラメント縫合糸である。Polycaprolactone polymers have favorable properties as sutures, such as being non-toxic and being gradually decomposed and absorbed within living tissues. Polycaprolactone polymers used for coating sutures in this type of field have a relative viscosity of 1.8 to 1.5, but in the present invention, the relative viscosity is 2.
.. 0 to 8.2, the Young's modulus is small, and therefore,
It is a flexible monofilament suture.
また、上記した本発明のポリカプロラクトンモノフィラ
メント縫合糸は、延伸後、アニーリング(熱処理)を施
すことにより、破断点伸びをコントロールすることがで
きる。破断点伸びは糸の弾性率と密接な関係にあり、一
般的には充分に延伸をして伸びの少ない糸となすと弾性
率が高くなり、伸びの大きな糸の場合には、弾性率が低
くなる。Further, the elongation at break of the polycaprolactone monofilament suture of the present invention described above can be controlled by subjecting it to annealing (heat treatment) after stretching. The elongation at break is closely related to the elastic modulus of the yarn, and in general, if the yarn is sufficiently drawn and has little elongation, the elastic modulus will be high, and if the yarn has a large elongation, the elastic modulus will increase. It gets lower.
ポリカプロラクトン重合体は、縫合糸として使用されて
きたポリマーの中では特に軟かいため、例えば破断点伸
びが100%以上のあるような糸ではしなやか過ぎて腰
がなく縫合糸としての性能が低下し、反対に破断点伸び
が15%以下では伸びが少ないため結節時の力の入れ方
に経験による慣れが必要となり、特に細い縫合糸の場合
には結節時に不用意に引き切ってしまうことがある。こ
のため取り扱いやすく、高い抗張力と週間な曲げ弾性率
とを保有するモノフィラメントの伸度は80〜80%で
あることが好ましい。Polycaprolactone polymer is particularly soft among the polymers that have been used as suture threads, so for example, threads with an elongation at break of 100% or more are too pliable and have no stiffness, reducing their performance as suture threads. On the other hand, if the elongation at break is less than 15%, there will be little elongation, so experience will be needed to get used to how to apply force when tying, and especially in the case of thin sutures, the suture may be accidentally torn when tying. . For this reason, the elongation of the monofilament, which is easy to handle and has high tensile strength and moderate flexural modulus, is preferably 80 to 80%.
また、生体吸収性の縫合糸としては、カットグツド、ポ
リグリコール酸、ポリグリコール酸・ポIJ L乳酸共
重合体やキチン等が知られているが、これらは、吸収性
縫合糸として適切でない特質がある。例えば、カットグ
ツドは糸が硬くて取扱いにくく吸収性をクロムでもって
調整しているが製品間に吸収性のバラツキがみられ、生
体適合性もあまり良好ではない。ポリグリコール酸は充
分な引張り強度を有し、溶解性のバラツキも少なく安定
しているが、ポリマーが硬いために通常使用されている
太さのモノフィラメント縫合糸となすことは困難である
。また、キチン繊維は溶解性がよいが湿潤時に膨潤して
抗張力が低下する。しかしながら、本発明による縫合糸
は、軟かく乾湿強度差が小さく、更にカットグツト、ポ
リグリコール酸、ポリグリコール酸・ポリL乳酸共重合
体、キチン等の縫合糸に比べて溶解速度が遅く、手術後
の縫合糸の強力が長時間持続するから、長時間の縫合保
持張力を要する部位、例えば、心臓血管、臓器移植、成
長期における小児外科用として最適となる。In addition, bioabsorbable sutures such as catgut, polyglycolic acid, polyglycolic acid/PoIJL-lactic acid copolymer, and chitin are known, but these have characteristics that make them unsuitable as absorbable sutures. be. For example, Katgutsudo's thread is hard and difficult to handle, and its absorbency is adjusted with chromium, but there are variations in absorbency between products, and its biocompatibility is not very good. Polyglycolic acid has sufficient tensile strength and is stable with little variation in solubility, but because the polymer is hard, it is difficult to form it into monofilament sutures of the commonly used thickness. Furthermore, chitin fibers have good solubility, but when wet, they swell and their tensile strength decreases. However, the suture according to the present invention is soft and has a small difference in dry and wet strength, and has a slower dissolution rate than sutures made of catgut, polyglycolic acid, polyglycolic acid/poly-L-lactic acid copolymer, chitin, etc., and after surgery. Because the strength of the suture lasts for a long time, it is ideal for areas that require long-term suture retention tension, such as cardiovascular surgery, organ transplantation, and pediatric surgery during the growing period.
そして、本発明のポリカプロラクトン縫合糸は、従来の
ポリプロピレンやナイロン等の縫合糸同様に針付けが容
易であり、片端または両端針付きポリカプロラクトンモ
ノフィラメント縫合糸となすことができ、また、エチレ
ンオキサイドのようなガス体の滅菌剤やa線のような放
射線滅菌等60℃を超えない穏々の低温滅菌法を適用す
ることができる。The polycaprolactone suture of the present invention can be easily attached with needles like conventional sutures made of polypropylene or nylon, and can be made into a polycaprolactone monofilament suture with needles at one or both ends. Gentle low temperature sterilization methods at temperatures not exceeding 60° C., such as gaseous sterilizers such as sterilizers and radiation sterilization such as A-rays, can be applied.
更に、溶融紡糸のときにチタンホワイト、フタロシアニ
ンブルーのような人体に安全で熱安定性の染料を用いる
ことにより着色された縫合糸とすることもできる。Furthermore, the suture thread can be colored by using a heat-stable dye that is safe for the human body, such as titanium white or phthalocyanine blue, during melt spinning.
本発明の縫合糸に用いられる熱可塑性ポリカプロラクト
ン重合体は以下のようにして製造される。The thermoplastic polycaprolactone polymer used in the suture of the present invention is produced as follows.
すなわち、ε−カプロラクトンモノマーなどのラクトン
モノマーを活性水素基を有する開始剤および触媒の存在
下で開環付加重合させることにより得られる。That is, it is obtained by ring-opening addition polymerization of a lactone monomer such as ε-caprolactone monomer in the presence of an initiator and a catalyst having an active hydrogen group.
この反応に用いられる触媒としては有機スズ化金物、有
機チタン化合物、有機ハロゲン化スズ化合物などが一般
的であり、その使用量は出発原料に対して0.1〜5,
000 ppm、好ましくは10〜1o o ppm
である。反応温度は100〜280℃が適当であり、不
活性ガス中で行なうのがよい。Catalysts used in this reaction are generally organotin metal compounds, organotitanium compounds, organohalogenated tin compounds, etc., and the amount used is 0.1 to 5,000 m
000 ppm, preferably 10-100 ppm
It is. The reaction temperature is suitably 100 to 280°C, and preferably carried out in an inert gas atmosphere.
反応温度は280℃以上にすることは好ましくない。と
いうのはポリカプロラクトンの解重合温度が約280〜
280℃であるため、これ以上の高温度で反応を行なう
と重合物が分解し、分子量が大きくならないからである
。反対に反応温度が100℃以下では反応速度が遅く、
効率が悪い。It is not preferable for the reaction temperature to be higher than 280°C. This is because the depolymerization temperature of polycaprolactone is about 280 ~
This is because the temperature is 280°C, and if the reaction is carried out at a higher temperature, the polymer will decompose and the molecular weight will not increase. On the other hand, when the reaction temperature is below 100°C, the reaction rate is slow;
ineffective.
この熱可塑性ポリカプロラクトン重合体は常温で液体の
ものから固体状のもの迄種々の分子量(すなわち、相対
粘度)を有するものがあり、各種の用途に用いられてい
るが、本発明の縫合糸に用いられるポリカプロラクトン
重合体は相対粘度2.0〜8.2のものである。This thermoplastic polycaprolactone polymer has various molecular weights (i.e., relative viscosities) ranging from liquid to solid at room temperature, and is used for various purposes. The polycaprolactone polymer used has a relative viscosity of 2.0 to 8.2.
なお、相対粘22.0〜8.2を有するポリカプロラク
トン重合体は各種の用途向けに市販されており、たとえ
ば、倍力操作用物体(特開昭6O−240692)、プ
ラスチック粘土(特開昭6l−42679)、医療用ギ
プス(特開昭58−81042Lスプリント材、放射線
照射用フェイスマスク、かつらの型取材(特開昭60−
215018)などに用いられている。Polycaprolactone polymers having a relative viscosity of 22.0 to 8.2 are commercially available for various uses, such as boosting objects (Japanese Patent Laid-Open No. 6O-240692), plastic clay (Japanese Patent Laid-Open No. 60-240692), 6l-42679), medical cast (Japanese Patent Laid-open No. 58-81042L splint material, face mask for radiation irradiation, wig mold coverage (Japanese Patent Laid-open No. 60-810-
215018), etc.
相対粘度2.0〜8.2を有するポリカプロラクトン重
合体の具体的な例としては、ダイセル化学工業株式会社
で製造され、市販されているPCL−H4,H7などが
ある。Specific examples of polycaprolactone polymers having a relative viscosity of 2.0 to 8.2 include PCL-H4 and H7, which are manufactured by Daicel Chemical Industries, Ltd. and are commercially available.
なお、相対粘度はJI8規格(K−6726)に準じ、
溶剤:トルエン、濃度=1%、温度=25±0.05℃
で測定する。In addition, relative viscosity is according to JI8 standard (K-6726),
Solvent: Toluene, concentration = 1%, temperature = 25 ± 0.05°C
Measure with.
(作用)
相対粘度2.0〜8.2のポリカプロラクトン重合体を
□溶融紡糸し、延伸して得られたポリカプロラクトンモ
ノフィラメント縫合糸は、モノフィラメントでありなが
らヤング率が小さり、シかも直線引張抄強さ並びに結節
強さに優れている。従って、医療用の縫合糸として好都
合な性能を発揮し、縫合部位を長時間に亘り締結すると
ともにその間冷々に生体内に吸収され、生体組織の治癒
Iζ時間のかかる部位が確実に治癒するまで縫合保持作
用を持続する。(Function) The polycaprolactone monofilament suture obtained by melt-spinning and drawing a polycaprolactone polymer with a relative viscosity of 2.0 to 8.2 has a small Young's modulus even though it is a monofilament, and has a linear tensile strength. Excellent paper strength and knot strength. Therefore, it exhibits favorable performance as a medical suture thread, fastens the suture site for a long period of time, and is coolly absorbed into the body during that time, so that it can be used to suture areas that take time to heal the living tissue. Maintains retention effect.
(実施例)
実施例1
相対粘度2,84の樹脂(ダイセル化学工業株式会社製
ポリカプロラクトン重合体:PC!L−H?)をノズル
温度220℃で溶融紡糸し、紡糸後、直ちに26°Cの
冷却水で6秒間冷却したのち毎分6mの速度で巻取った
。しかるのち、第1段階において、25℃の空気中で5
.0倍に延伸し、第2段階において、52℃の温水中で
1.6倍に延伸して太さ0.246ffのポリカプロラ
クトンモノフィラメント縫合糸を得た。(Example) Example 1 A resin with a relative viscosity of 2.84 (polycaprolactone polymer manufactured by Daicel Chemical Industries, Ltd.: PC!L-H?) was melt-spun at a nozzle temperature of 220°C, and immediately after spinning, the resin was spun at 26°C. After cooling with cooling water for 6 seconds, it was wound up at a speed of 6 m/min. Then, in the first stage, the
.. The polycaprolactone monofilament suture thread was stretched 0 times, and then stretched 1.6 times in warm water at 52° C. in the second stage to obtain a polycaprolactone monofilament suture having a thickness of 0.246 ff.
実施例2
上記実施例1により得られたポリカプロラクトンモノフ
ィラメント縫合糸を、アニーリングのために58°Cの
乾熱で無張力状態で約20分間処理し、アニーリングを
施したポリカプロラクトンモノフィラメント0合糸とな
した。Example 2 The polycaprolactone monofilament suture obtained in Example 1 above was treated with dry heat at 58°C for about 20 minutes under no tension for annealing, resulting in an annealed polycaprolactone monofilament 0-ply yarn. I did it.
比較例1
相対粘度1.58の樹脂(ダイセル化学工業株式会社製
ポリカプロラクトン重合体:PCT、−H4)をノズル
温度100°Cで溶融紡糸し、紡糸後、直ちに25℃の
冷却水で5秒間冷却したのち、毎分4mの速度で巻取っ
た。しかるのち、25℃の空気中で7.8倍に延伸し、
太さ0.246flのポリカプロラクトンモノフィラメ
ント縫合糸となした。Comparative Example 1 A resin with a relative viscosity of 1.58 (polycaprolactone polymer: PCT, -H4 manufactured by Daicel Chemical Industries, Ltd.) was melt-spun at a nozzle temperature of 100°C, and immediately after spinning, it was spun with cooling water at 25°C for 5 seconds. After cooling, it was wound up at a speed of 4 m/min. After that, it was stretched 7.8 times in air at 25°C,
A polycaprolactone monofilament suture having a thickness of 0.246 fl was made.
その他、市販のポリプロピレンモノフィラメント縫合糸
(太さ0.281ff)およびナイロンモノフィラメン
ト縫合糸(太さ0.286J111)をそれぞれ比較例
2および比較例8とした。In addition, commercially available polypropylene monofilament suture thread (thickness 0.281 ff) and nylon monofilament suture thread (thickness 0.286J111) were used as Comparative Example 2 and Comparative Example 8, respectively.
上記実施例1,2及び比較例1〜3についての直線引張
り強さ、破断点伸び、結節強さ並びにヤング率を測定し
た。その結果を@1表に示す。The linear tensile strength, elongation at break, knot strength, and Young's modulus of Examples 1 and 2 and Comparative Examples 1 to 3 were measured. The results are shown in Table @1.
(以下余白)
第 1 表
(註)直線引張り強さは、約203の試料糸をチャック
間101のテンシロン(東洋ボールドウィン社製RTM
−100)にセットし、毎分100顛の速度で伸ばし、
切断したときの負荷をその数値とした。破断点伸びは、
上記直線引張り強さの切れたときの伸びの数値とした。(Margins below) Table 1 (Note) Linear tensile strength is measured using Tensilon (Toyo Baldwin RTM manufactured by Toyo Baldwin Co., Ltd.) with approximately 203 sample yarns between 101 chucks.
-100) and stretch at a speed of 100 frames per minute.
The load at the time of cutting was taken as that value. The elongation at break is
The value was taken as the elongation at the break of the above linear tensile strength.
結節強さは約20011の試料糸のほぼ中央部に1回結
び部を作り、上記テンシロンのチャック間にセットして
毎分100Mの速度で伸ばし、切断した時点の負荷を数
値とした。ヤング率は直線引張り強さを測定したチャー
トの立上がりの傾きから計算式により求めた。また、第
1表中の実施例2の湿強度は87℃の生理的食塩水中に
1時間浸漬したものを測定した。For the knot strength, a knot was made once at approximately the center of a sample thread of approximately 20011, set between the chucks of the Tensilon, stretched at a speed of 100 M/min, and the load at the time of cutting was taken as a numerical value. Young's modulus was determined by a formula from the slope of the rise of the chart that measured the linear tensile strength. Further, the wet strength of Example 2 in Table 1 was measured after being immersed in physiological saline at 87° C. for 1 hour.
実施例8
実施例1で用いたポリカプロラクトン重合体を実施例1
と同じ方法で、4−0相当の縫合糸(直径0.195f
f)にし、家兎背筋に埋入し、2ケ月、4ケ月、6ケ月
、8ケ月、10ケ月及び12ケ月後に取り出して約20
3の試料糸となし、それぞれの直線引張り強さ、埋入前
の試料糸に対する抗張力残存率及び伸度を測定した。そ
の結果を第2表に示す。Example 8 The polycaprolactone polymer used in Example 1 was
Using the same method as above, use a 4-0 equivalent suture (diameter 0.195f
f) and implanted into the dorsal muscle of a rabbit, and removed after 2 months, 4 months, 6 months, 8 months, 10 months, and 12 months.
The linear tensile strength, residual tensile strength and elongation of the sample threads before implantation were measured for each sample thread. The results are shown in Table 2.
実施例4
実施例8の縫合糸を87℃生理的食塩水中に浸漬し、2
ケ月、4ケ月、6ケ月、8ケ月、10ケ月及び12ケ月
後に取り出した各試料糸の直線引張り強さ、抗張力残存
率及び伸度を測定した。その結果を第2表に示す。Example 4 The suture of Example 8 was immersed in 87°C physiological saline and
The linear tensile strength, residual tensile strength, and elongation of each sample yarn taken out after 1 month, 4 months, 6 months, 8 months, 10 months, and 12 months were measured. The results are shown in Table 2.
(発明の効果)
以上、実施例において詳記した通り、本発明によるポリ
カプロラクトンモノフィラメント縫合糸は、モノフィラ
メントであるにも拘らず極めてしなやかであり、したが
って取扱いやすく、更に生体内における溶解速度が遅く
長期間縫合保持張力を有するから、通常よりも組織の治
癒に時間のかかる部位の縫合用として好適となり、この
種の部位の外科用縫合糸として顕著な効果を特徴する特
許出願人 日本商事株式会社(Effects of the Invention) As described above in detail in the Examples, the polycaprolactone monofilament suture according to the present invention is extremely flexible despite being a monofilament, and therefore easy to handle, and has a slow dissolution rate in vivo and a long length. Because it has suture retention tension for a long period of time, it is suitable for suturing areas where tissue healing takes longer than usual, and it is characterized by remarkable effects as a surgical suture thread for this type of area.Patent applicant: Nippon Shoji Co., Ltd.
Claims (2)
合体からなる延伸された外科用モノフィラメント縫合糸
。(1) A drawn surgical monofilament suture consisting of a polycaprolactone polymer with a relative viscosity of 2.0 to 8.2.
いる特許請求の範囲第1項記載の外科用モノフィラメン
ト縫合糸。(2) The surgical monofilament suture according to claim 1, wherein a needle is attached to one or both ends of the suture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62335283A JP2520678B2 (en) | 1987-12-30 | 1987-12-30 | Surgical monofilament suture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62335283A JP2520678B2 (en) | 1987-12-30 | 1987-12-30 | Surgical monofilament suture |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01175855A true JPH01175855A (en) | 1989-07-12 |
JP2520678B2 JP2520678B2 (en) | 1996-07-31 |
Family
ID=18286785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62335283A Expired - Fee Related JP2520678B2 (en) | 1987-12-30 | 1987-12-30 | Surgical monofilament suture |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2520678B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090910A (en) * | 1996-12-10 | 2000-07-18 | Mitsui Chemicals, Inc. | Degradable monofilament and preparation process thereof |
WO2009031660A1 (en) * | 2007-09-07 | 2009-03-12 | Kawamoto Corporation | Hygienic material for surgery |
CN111372969A (en) * | 2017-11-20 | 2020-07-03 | 瑞比奥科技公司 | Composition comprising a metal oxide and a metal oxide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5982865A (en) * | 1982-10-01 | 1984-05-14 | エチコン・インコ−ポレ−テツド | Operation product consisting of glicolide and caprolactone copolymer |
JPS6145764A (en) * | 1984-07-30 | 1986-03-05 | フアイザー・ホスピタル・プロダクツ・グループ・インコーポレーテツド | Hard elastic suturing yarn |
-
1987
- 1987-12-30 JP JP62335283A patent/JP2520678B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5982865A (en) * | 1982-10-01 | 1984-05-14 | エチコン・インコ−ポレ−テツド | Operation product consisting of glicolide and caprolactone copolymer |
JPS6145764A (en) * | 1984-07-30 | 1986-03-05 | フアイザー・ホスピタル・プロダクツ・グループ・インコーポレーテツド | Hard elastic suturing yarn |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6090910A (en) * | 1996-12-10 | 2000-07-18 | Mitsui Chemicals, Inc. | Degradable monofilament and preparation process thereof |
WO2009031660A1 (en) * | 2007-09-07 | 2009-03-12 | Kawamoto Corporation | Hygienic material for surgery |
JP2009061186A (en) * | 2007-09-07 | 2009-03-26 | Kawamoto Sangyo Kk | Hygienic material for surgery |
CN111372969A (en) * | 2017-11-20 | 2020-07-03 | 瑞比奥科技公司 | Composition comprising a metal oxide and a metal oxide |
Also Published As
Publication number | Publication date |
---|---|
JP2520678B2 (en) | 1996-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5854383A (en) | Aliphatic polyesters of trimethylene carbonate epsilon-caprolactone and glycolide | |
JP5280839B2 (en) | Absorbable / biodegradable composite yarn and property-adjusting surgical implant formed therefrom | |
JP4667853B2 (en) | High strength suture and suture anchor combination with an absorbent core | |
JP4850413B2 (en) | High-strength suture with absorbent core | |
US5236444A (en) | Absorbable polymers and surgical articles made therefrom | |
US5530074A (en) | Coating for tissue drag reduction | |
US5951997A (en) | Aliphatic polyesters of ε-caprolactone, p-dioxanone and gycolide | |
JPS60185562A (en) | Surgical prosthesis | |
Benicewicz et al. | Polymers for absorbable surgical sutures—Part I | |
JP2007525601A (en) | Polyhydroxyalkanoate medical fabric and medical fiber | |
JPH08206189A (en) | Surgical suture material,its application at time of surgery,and its manufacture | |
Chellamani et al. | Surgical sutures: an overview | |
JP3740521B2 (en) | Triblock terpolymers, their use in surgical suture materials and their preparation | |
Koshak | Dental suturing materials and techniques | |
US5797962A (en) | Surgical suture and method for preparation thereof | |
Lober et al. | Suture materials for closing the skin and subcutaneous tissues | |
STASHAK et al. | Considerations for selection of suture materials | |
Afewerki et al. | Polymers for surgical sutures | |
CN113694246A (en) | Biodegradable surgical suture and preparation method thereof | |
JPH01175855A (en) | Surgical monofilament seaming thread | |
Kronenthal | Intraocular degradation of nonabsorbable sutures | |
KR102459980B1 (en) | Absorbable suture containing hyaluronic acid and method for manufacturing the same | |
Veeraraghavan | Wound Closure and Care in Oral and Maxillofacial Surgery | |
KR102393316B1 (en) | Absorbable suture containing polydeoxyribonucleotide | |
HU180417B (en) | Catgut strings having improved knotting characteristics and pulling the live tissues just slightly |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |